...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation

Clinical Evidence
Investigational Status
Research Summary

Women’s Health Clinic FAQ

Is the O-Shot medically proven?

The medical status of the O-Shot® is a topic of intense clinical interest. While it is not yet classified as a 'standard of care,' a growing body of peer-reviewed research is validating its effectiveness for female sexual health and urinary control.

Direct answer

The O-Shot is currently classified as an 'investigational' treatment, meaning it is supported by significant clinical data but has not yet been adopted into routine NHS or universal practice guidelines. However, high-impact studies—including a 2024 Randomized Controlled Trial (RCT) published in 'Obstetrics & Gynecology' and a 2025 review by Isokova—have demonstrated statistically significant improvements in sexual arousal, lubrication, and 'Abdominal Leak Point Pressure' (a measure of urinary control). The 'proof' depends on whether one looks at the trademarked O-Shot protocol (which includes clitoral and vaginal injections) or generic PRP studies; research following the full trademarked protocol consistently shows higher efficacy rates than studies that only inject the vaginal wall.

It is important for patients to understand that while 'proven' in many clinical trials, the procedure remains 'off-label.' This means individual results vary and the treatment should be performed as part of a structured clinical framework by a regulated professional.

Educational only. Objective review of the clinical evidence and current regulatory standing of the O-Shot. Results vary. Not a cure.

Clinical data chart showing improvements in sexual function scores
RESEARCH DATA

At a glance

The following table summarizes the current state of scientific evidence regarding the O-Shot's primary benefits.

Evidence Summary

Clinical Findings

Sexual Function

Significant (RCT Validated)

Urinary Incontinence

Improved (ALPP Data)

Tissue Health

Documented Regeneration

Safety Record

High (Autologous)

The 'Protocol Gap'

Many negative or neutral studies of vaginal PRP fail because they omit the clitoral injection—a mandatory part of the O-Shot. When the full protocol is followed, success rates are significantly higher.

RCT Supported (2024)
Statistical Significance
Investigational Status
Peer Reviewed
ALPP Improvements




Detailed answer

The Science of Success

Clinical proof is measured through standardized scoring systems and physical markers of health.

Measurable Clinical Markers

Doctors use specific tests to prove that the O-Shot is doing more than just providing a placebo effect.

FSFI Scores
ALPP Pressure
Urethral Resistance
Mucosal Health

FSFI Improvement

The Female Sexual Function Index (FSFI) is a standardized test. Research shows a significant jump in arousal and satisfaction scores post-O-Shot.

ALPP Metrics

Abdominal Leak Point Pressure measures how much stress the bladder can take. Studies show increased resistance after O-Shot injections.

Histological Changes

Biopsies have shown that PRP triggers the growth of new blood vessels (angiogenesis) and thicker vaginal epithelium.

Nerve Rejuvenation

While harder to measure, sensory testing has shown improved clitoral sensitivity, suggesting a functional repair of nerve endings.

Standard of Care vs. Experimental

In medicine, moving from 'proven in trials' to 'Standard of Care' takes decades. The O-Shot is currently in the middle of this journey—widely used in private medicine but still being evaluated for universal healthcare.

This 'experimental' label does not mean it doesn't work; it simply means we are still gathering the 10+ years of data required for full global standardization.





Patient safety

Why Peer-Review Matters

Not all 'proof' is equal. We look at the highest levels of scientific evidence.

Blinded RCTs

The 2024 Clarke study was a Randomized Controlled Trial—the gold standard of proof—and showed real benefits for sexual health.

Global Consensus

Reviews from the US, UK, and Japan are beginning to align on the safety and efficacy of PRP for Genitourinary Syndrome of Menopause (GSM).

Expert Endorsement

Thousands of board-certified gynaecologists globally now offer the O-Shot, based on their own clinical observations and patient outcomes.

Patient Outcomes

While 'anecdotal,' the consistent report of improved orgasms and reduced leakage across thousands of patients provides real-world validity.

Evidence-Based Practice

We follow an evidence-based approach, combining the latest research with clinical expertise and your individual needs.

We do not rely on marketing claims; we rely on the measurable markers of improvement found in the medical literature.





Considerations

Factors Affecting Efficacy

Even with 'proven' science, the success of your specific treatment depends on several variables.

Individual Response

Because PRP is autologous (from you), your own baseline health affects the 'strength' of the growth factors being injected.

Age Factors
Platelet Quality
Hormone Levels
Protocol Adherence

Vascular Health

Women with better baseline blood flow often see faster results, as the PRP signaling pathways are more active.

Platelet Concentration

Using a medical-grade centrifuge ensures we reach the 3x-5x concentration needed to trigger a clinical response.

Lifestyle Habits

Smoking and heavy alcohol use can dampen the regenerative effect. We recommend a clean lifestyle for 2 weeks pre-procedure.

Maintenance

Research suggests that the 'proof' of results is most visible between months 3 and 12, with annual top-ups often required.

Predicting Your Success

During your consultation, we use the same FSFI screening tools used in clinical trials to establish your baseline and predict your response rate.

We are transparent about who is likely to benefit and who may require alternative or adjunctive treatments.





Common concerns and myths

Proof Myths and Realities

Clarifying the difference between clinical proof and regulatory approval.

Myth: FDA Approved for Sex

Reality: The O-Shot is NOT FDA-approved specifically for sexual dysfunction. It is used 'off-label,' which is a common and legal medical practice.

Myth: It works for everyone

Reality: No medical treatment is 100% effective. Success rates in studies typically range from 70% to 90%.

Myth: It's just a 'trend'

Reality: PRP has over 30 years of history in medicine. Its application to intimate health is the natural evolution of that science.

Myth: If it's not on the NHS, it's not proven

Reality: Many treatments (like some IVF protocols or advanced lasers) are clinically proven but not yet funded by public health budgets.

Myth: The research is biased

Reality: Recent RCTs are independent and use 'double-blind' protocols to ensure the data is objective and reliable.





Safety checklist

How to Read the Research

If you are researching the O-Shot yourself, look for these markers of high-quality scientific evidence.

Study Sample Size

Was the study performed on a large group of women or just a few cases?

Control Groups

Did the study compare the O-Shot against a 'sham' or placebo injection?

Follow-Up Duration

Did the researchers track results for at least 6 to 12 months?

Standardized Metrics

Did they use validated tools like the FSFI or Urogenital Distress Inventory?

Evidence 'Green Flags'

Papers published in major journals like 'Obstetrics & Gynecology' carry the most clinical weight.

Peer Reviewed
Blinded Trials
High Citations

Evidence 'Red Flags'

Be wary of clinics citing 'studies' that are actually just internal surveys or non-peer-reviewed blog posts.

Non-Peer Reviewed
Short Term Only
Marketing Focus




When to escalate

Evaluating Your Results

Clinical proof is important, but your personal experience is the final measure of success. Schedule Evaluation

The Placebo Factor

While studies use controls to rule out placebo, your mental health and relationship satisfaction still play a role in your results.

Realistic Expectations

The O-Shot is proven to improve function, but it is not a 'magic wand' for complex relational or deep psychological trauma.

Hormonal Foundations

If you have severe hormone deficiency, the O-Shot is most 'proven' when used alongside (not instead of) appropriate hormone therapy.

Long-Term Monitoring

We monitor your progress at 6 and 12 weeks to ensure you are meeting the benchmarks found in the clinical literature.

Individual results may vary. This overview summarizes general research findings and not a guarantee of individual outcomes.

Deep Dive: The Clarke et al. 2024 Study

A Milestone for Regenerative Gynaecology

The 2024 Randomized Controlled Trial by Clarke and colleagues is a watershed moment. By using a 'sham' injection group, the researchers were able to prove that the improvements in sexual function scores in the PRP group were due to the biological effects of the platelets, not just the psychological effect of having a procedure.

Why Study Design Matters

Historically, PRP was criticized for lacking 'level 1' evidence. This new study provides that evidence. It showed that women treated with PRP had significantly higher scores in the 'Arousal,' 'Lubrication,' and 'Orgasm' domains of the FSFI than those in the placebo group. While the study didn't follow the clitoral injection protocol of the O-Shot, its success even with a limited protocol reinforces the underlying science of vaginal PRP.

The Path to Standardization

As more of these studies are published, we move closer to a world where regenerative gynaecology is the first choice for women's health. We are currently participating in data collection efforts to help build the long-term surveillance database that will eventually move the O-Shot into standard medical guidelines.

Next step

Proven Results Await

Don't settle for speculation. Base your health decisions on the science. Book your O-Shot consultation today to discuss the research and your potential for success.

Research Evidence: Obstetrics & Gynecology (2024); International Journal of Integrative and Modern Medicine (2025); FSFI Standardized Metrics.

Educational only. The O-Shot is an investigational medical procedure. Always discuss the latest research and clinical trial data with your healthcare provider. Results vary. Not a cure.

Loading directory...